Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 35,219 | 8,198 | 327 | 11,043 | 4,050 |
| Cost of Goods | 10,172 | 10,934 | N/A | N/A | N/A |
| Gross Profit | 25,047 | -2,736 | 327 | 11,043 | 4,050 |
| Operating Expenses | 160,062 | 151,517 | 96,332 | 121,750 | 109,123 |
| Operating Income | -134,843 | -153,319 | -96,005 | -110,707 | -105,073 |
| Interest Expense | 16,977 | 9,338 | 0 | 0 | 572 |
| Other Income | -780 | 3,758 | 851 | -1,737 | -1,149 |
| Pre-tax Income | -152,600 | -158,899 | -95,154 | -112,444 | -106,794 |
| Net Income Continuous | -152,600 | -158,899 | -95,154 | -112,444 | -106,794 |
| Net Income | $-152,600 | $-158,899 | $-95,154 | $-112,444 | $-106,794 |
| EPS Basic Total Ops | -2.16 | -2.55 | -1.81 | -2.92 | -3.25 |
| EPS Basic Continuous Ops | -2.12 | -2.55 | -1.81 | -2.92 | -3.25 |
| EPS Diluted Total Ops | -2.16 | -2.55 | -1.81 | -2.92 | -3.25 |
| EPS Diluted Continuous Ops | -2.12 | -2.55 | -1.81 | -2.92 | -3.25 |
| EPS Diluted Before Non-Recurring Items | -1.87 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-114,775 | $-140,395 | $-91,760 | $-108,272 | $-103,048 |